Diabetes, Glycemic Control, and Risk of Hospitalization With Pneumonia: A population-based case-control study by Kornum, Jette B. et al.
Diabetes, Glycemic Control, and Risk of
Hospitalization With Pneumonia
A population-based case-control study
JETTE B. KORNUM, MD
1
REIMAR W. THOMSEN, MD, PHD
1
ANDERS RIIS, MSC
1
HANS-HENRIK LERVANG, MD, PHD
2
HENRIK C. SCHØNHEYDER, MD, DMSC
3
HENRIK T. SØRENSEN, MD, DMSC
1
OBJECTIVE — To examine whether diabetes is a risk factor for hospitalization with pneu-
monia and to assess the impact of A1C level on such risk.
RESEARCH DESIGN AND METHODS — In this population-based, case-control study
we identiﬁed patients with a ﬁrst-time pneumonia-related hospitalization between 1997 and
2005,usinghealthcaredatabasesinnorthernDenmark.Foreachcase,10sex-andage-matched
population control subjects were selected from Denmark’s Civil Registration System. We used
conditional logistic regression to compute relative risk (RR) for pneumonia-related hospitaliza-
tion among subjects with and without diabetes, controlling for potential confounding factors.
RESULTS — The study included 34,239 patients with a pneumonia-related hospitalization
and 342,390 population control subjects. The adjusted RR for pneumonia-related hospitaliza-
tion among subjects with diabetes was 1.26 (95% CI 1.21–1.31) compared with nondiabetic
individuals. The adjusted RR was 4.43 (3.40–5.77) for subjects with type 1 diabetes and 1.23
(1.19–1.28) for subjects with type 2 diabetes. Diabetes duration 10 years increased the risk of
a pneumonia-related hospitalization (1.37 [1.28–1.47]). Compared with subjects without dia-
betes,theadjustedRRwas1.22(1.14–1.30)fordiabeticsubjectswhoseA1Clevelwas7%and
1.60 (1.44–1.76) for diabetic subjects whose A1C level was 9%.
CONCLUSIONS — Type 1 and type 2 diabetes are risk factors for a pneumonia-related
hospitalization. Poor long-term glycemic control among patients with diabetes clearly increases
the risk of hospitalization with pneumonia.
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H
ospitalizations with pneumonia
have increased by 20–50% in
Western populations during the
past 10 years (1,2). Combined with inﬂu-
enza, pneumonia is the seventh leading
cause of death in the U.S. (3).
Diabetes is thought to be a risk factor
for pneumonia, but available data are few
and inconclusive (4–11). Diabetic sub-
jects may have increased susceptibility to
pneumonia for several reasons. They are
at increased risk of aspiration, hypergly-
cemia, decreased immunity, impaired
lung function, pulmonary microangiopa-
thy, and coexisting morbidity (12). Five
cohort studies (4,6,8–10) found that dia-
betes is a risk factor for pneumonia, with
relative risks (RRs) ranging from 1.30 to
1.75,whilethreestudies(5,7,11)failedto
ﬁnd an association. Existing studies have
limitations: some included only patients
aged 60 years (8,10,11), one did not
adjust for comorbidity (9), and few were
population-based (9,11). Only one study
(6) of respiratory tract infections distin-
guishedbetweentype1andtype2diabetes.
Immunologic abnormalities in dia-
betic subjects are related in part to the
harmful effects of hyperglycemia (12).
Recently, a cohort study (4) encompass-
ing 10,063 subjects followed for 7 years
foundthateach1mmol/lincreaseinbase-
line plasma glucose was associated with a
6% increase in the RR of pneumonia.
However,thisresultwasbasedonasingle
nonfasting glucose measurement. The
impact of poor long-term glycemic con-
trol on risk of pneumonia-related hospi-
talization still remains uncertain.
Given the rising incidence of pneu-
monia-related hospitalizations (1,2) and
the increasing prevalence of diabetes
(13), it is important to clarify whether di-
abetes and poor long-term glycemic con-
trol is a risk factor for pneumonia. We
examined whether diabetes is associated
with an increased risk of pneumonia-
related hospitalization and whether this
risk is modulated by A1C level.
RESEARCH DESIGN AND
METHODS— We conducted this
population-based, case-control study in
the Danish counties of North Jutland and
Aarhus, with a mixed rural and urban
population of 1.15 million people. The
Danish National Health service provides
tax-supported health care for all resi-
dents, including free access to primary
care and hospitals and reimbursement of
a portion of the cost of most prescription
drugs (14). Civil registration numbers,
unique identiﬁers assigned to each Dan-
ish citizen that encode birth date and sex,
allow accurate linkage among registries.
Identiﬁcation of patients
hospitalized with pneumonia
Hospital registries in Aarhus and North
Jutland counties contain information on
all hospitalizations since 1977 and on all
outpatient visits since 1995. Data include
dates of admission and discharge and up
to 20 discharge diagnoses coded by phy-
sicians according to the ICD-10 during
the study period and ICD-8 before 1994.
We identiﬁed all inpatients with the
following ﬁrst-time discharge diagnoses
recorded between 1997 and 2005: pneu-
monia (J12.x–J18.x), legionellosis
(A481.x.), and ornithosis (A709.x) (n 
41,850) (2). We excluded 3,977 patients
who lived in the counties 12 months
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
From the
1Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg, Denmark; the
2De-
partment of Endocrinology, Aarhus University Hospital, Aalborg, Denmark; and the
3Department of
Clinical Microbiology, Aarhus University Hospital, Aalborg, Denmark.
Corresponding author: Jette B. Kornum, j.kornum@rn.dk.
Received 21 January 2008 and accepted 10 May 2008.
Published ahead of print at http://care.diabetesjournals.org on 16 May 2008. DOI: 10.2337/dc08-0138.
© 2008 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for proﬁt, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Epidemiology/Health Services Research
ORIGINAL ARTICLE
DIABETES CARE, VOLUME 31, NUMBER 8, AUGUST 2008 1541before the admission date and also ex-
cluded 18 patients born between 1894
and 1906, for whom we could not ﬁnd
control subjects, and 3,616 patients aged
15years,leaving34,239adultcasesub-
jects in the ﬁnal analysis set.
Selection of population control
subjects
TheCentralPopulationRegistry,whichis
updateddaily,containselectronicrecords
of all changes in vital status, including
changeofaddress,dateofemigration,and
date of death, for the entire Danish pop-
ulation since 1968. On the date of each
patient’s ﬁrst pneumonia-related hospital
admission (the index date), we randomly
selected10controlsubjectsfromtheCen-
tral Population Registry, matched by age
(same year of birth), sex, and residence
(the same county). We used the risk set
sampling technique (i.e., eligible control
subjectshadtobealiveandatriskofaﬁrst
hospitalization with pneumonia as re-
corded in their hospital discharge history
on the date the corresponding case was
admitted) (15).
Data on diabetes
For both case and control subjects, we
identiﬁed subjects with diabetes from
three databases: hospital registries, pre-
scription databases, and the Danish Na-
tional Health Service Registry. We used
the hospital registries to identify all sub-
jects with a discharge or outpatient diag-
nosis of diabetes since 1977 based on the
following ICD-codes: ICD-8 codes 249–
250 (diabetes) and ICD-10 codes E10–
E14 (diabetes), O24 (diabetes in
pregnancy except for O24.4, which is di-
abetes arising in pregnancy), and H36.0
(diabeticretinopathy)(16).Fromthepre-
scription database, which tracks ﬁlled
prescriptions for reimbursed drugs dis-
pensed by pharmacies in North Jutland
County since 1991 and in Aarhus County
since1996,weidentiﬁedallsubjectswith
at least one recorded prescription for in-
sulin or an oral antidiabetes drug. The
Danish National Health Service Registry
contains data on all citizens receiving
health services, their providers, and spe-
ciﬁc health services received (17). This
registry allowed us to identify subjects
who had at least one visit to a chiropodist
for diabetic foot care and/or who had at
least ﬁve glucose-related services (blood
glucose measurements performed in gen-
eral practice) in 1 year and/or two glu-
cose-related services each year during 5
subsequent years. Patients with diabetes
were classiﬁed as type 1 (those with dia-
betes ﬁrst recorded before age 30 years,
using insulin monotherapy, and with no
history of oral antidiabetes medications)
or type 2 (the remaining diabetic pa-
tients). Duration of diabetes was com-
puted as the time elapsed between the
ﬁrst record of diabetes treatment and the
index date.
Data on A1C
We obtained information on A1C levels
for diabetic subjects through linkage with
the counties’ laboratory databases. These
databasescontaininformationonallspec-
imens submitted for analysis by hospitals
and practitioners, including the exact
time of blood sample collection. One or
more measurements in the 12 months
preceding the index hospital admission
date were available for 2.731 (61%) pa-
tients. One or more measurements in the
12 months preceding the index hospital
admissiondateforthecorrespondingcase
subject were available for 16,605 (58%)
control subjects with diabetes. The most
recent A1C measurement before the in-
dex hospital admission date was used in
our analysis.
Data on confounding factors
Data on confounding factors were col-
lected from the hospital registries, the
prescription databases, and the Danish
Civil Registration System. Based on all
availablehospitaldiagnosesexceptdiabe-
tes,wecomputedaCharlsoncomorbidity
index score for each person (18). Three
comorbidity levels were deﬁned: low
(score of 0), medium (1–2), and high
(3). We also obtained data on several
factors not included in the Charlson in-
dex, including history of alcoholism-
related conditions (ICD-8 codes 291,
303,979,980,and577.10;ICD-10codes
F10, K86.0, Z72.1, R78.0, T51, K29.2,
G62.1, G72.1, G31.2, and I42.6), use of
immunosuppressants within the year be-
fore the pneumonia-related admission
(ATC codes L01, L04, and H02 AB), and
use of systemic antibiotics within 90 days
beforetheadmission(ATCcodeJ01).The
Central Population Registry provided
data on marital status (married, never
married, divorced or widowed, or marital
status unknown), subjects living with
small children attending day care centers
(aged 6 years, yes/no), and degree of
urbanization (residence in a rural area
with a population of 0–10,000, in a pro-
vincial town with a population of
10,000–100,000, or in a city with
100,000 inhabitants).
Statistical analysis
Weusedconditionallogisticregressionto
compute crude and adjusted odds ratios
(ORs) as a measure of RR, with associated
95%CIs,forpneumonia-relatedhospital-
ization among subjects with and without
diabetes. Diabetes exposure was further
categorized by type of diabetes, duration
of diabetes (5 years, 5t o10 years,
or 10 years), and A1C level (7.0%,
7.0to8.0%,8.0to9.0%,9.0%,
orunknown).Weadjustedforlevelofco-
morbidity, history of alcoholism-related
conditions, preadmission use of antibiot-
ics or immunosuppressants, marital sta-
tus, household presence of small children
attending day care centers, and degree of
urbanization. Stratiﬁed analyses were
performedbysex,age-group(15–39,40–
64, 65–79, and 80 years), and level of
comorbidity.Allanalyseswereconducted
usingStatasoftware(version9).TheDan-
ish Data Protection Agency approved the
study (record no. 2006-41-6226).
RESULTS
Descriptive data
Weidentiﬁed34,239patientswithaﬁrst-
time pneumonia-related hospitalization
(including 127 patients [0.37%] with le-
gionellsis and 16 patients [0.05%] with
ornithosis) and 342,390 population con-
trol subjects (Table 1). The study popula-
tion was 53% male and 47% female, with
a median age of 74 years. A total of 101
casesubjects(0.3%)and187controlsub-
jects (0.1%) were diagnosed with type 1
diabetes,and4,388casesubjects(12.8%)
and 28,299 control subjects (8.3%) were
diagnosed with type 2 diabetes predating
thecasesubjects’pneumonia-relatedhos-
pital admissions.
Risk estimates
The unadjusted RR for pneumonia-
related hospitalization among diabetic
subjects compared with nondiabetic sub-
jects was 1.68 (95% CI 1.62–1.74) and
the adjusted RR was 1.26 (95% CI 1.21–
1.31)(Table2).TheadjustedRRwas4.43
(3.40–5.77) for type 1 diabetic subjects
and 1.23 (1.19–1.28) for type 2 diabetic
subjects. Diabetes duration 10 years in-
creased the risk of pneumonia-related
hospitalization (1.37 [1.28–1.47]). Ex-
clusion of possible diabetes complica-
tions (i.e., myocardial infarction,
congestiveheartfailure,peripheralvascu-
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renal disease) from the Charlson index
and adjusting for the remaining disease
categoriesonlyinthemodelincreasedthe
effect of long-term diabetes (adjusted RR
for diabetes duration 10 years 1.62
[1.52–1.74]). Thus, 40% of the appar-
ent long-term diabetes effect was caused
byahigherprevalenceofrenal,cardiovas-
cular, and cerebrovascular disease. A1C
level also inﬂuenced the risk of pneumo-
nia-related hospitalization among dia-
betic subjects. Compared with
nondiabetic subjects, the RR was 1.22
(95% CI 1.14–1.30) among diabetic sub-
jects with an A1C level 7% and 1.60
(1.44–1.76) among diabetic subjects
with an A1C level 9% (Table 2). Using
only A1C measurements within 6 instead
of 12 months before admission yielded
virtually identical risk estimates.
Adult diabetic subjects aged 40
years were three times more likely to be
hospitalizedwithpneumoniathannondi-
abeticindividualsofsimilarage,whilethe
relativeriskgraduallydecreasedinelderly
subjects with diabetes (Table 3). After
stratifying by level of comorbidity, the as-
sociation between diabetes and the risk of
pneumonia-related hospitalization was
highest among subjects with no coexist-
ing morbidity (adjusted RR 1.51 [95% CI
1.41–1.61]). The same trends were ob-
served after further stratifying by diabetes
type (Table 3).
CONCLUSIONS — We found that
type 1 diabetes was associated with a 4.4-
fold increased risk of a pneumonia-
related hospitalization, and type 2
diabeteswasassociatedwitha1.2-foldin-
Table 1—Characteristics of case subjects with a ﬁrst-time hospitalization for pneumonia and
population control subjects from North Jutland and Aarhus Counties, Denmark, 1997–2005
Characteristic Case subjects Population control subjects
n 34,239 342,390
Diabetes
Absent 29,750 (86.9) 313,904 (91.7)
Present 4,489 (13.1) 28,486 (8.3)
Sex
Male 18,112 (52.9) 181,120 (52.9)
Female 16,127 (47.1) 161,270 (47.1)
Age (years) (median interquartile range) 74 (61–82) 74 (61–82)
Comorbidity index
Index low (0) 15,439 (45.1) 242,645 (70.9)
Index medium (1–2) 13,432 (39.2) 83,088 (24.3)
Index high (3) 5,368 (15.7) 16,657 (4.9)
Alcoholism-related conditions 1,732 (5.1) 4,955 (1.5)
Systemic antibiotic therapy 11,852 (34.6) 34,734 (10.1)
Immunosuppressants 5,994 (17.5) 21,681 (6.3)
Marital status
Married 15,863 (46.3) 178,814 (52.2)
Never married 4,225 (12.3) 38,601 (11.3)
Divorced or widowed 14,064 (41.1) 124,353 (36.3)
Unknown 87 (0.3) 622 (0.2)
Living with small children 1,273 (3.7) 11,124 (3.3)
Degree of urbanization
Rural 6,011 (17.6) 61,278 (17.9)
Provincial town 15,528 (45.4) 157,907 (46.1)
City 12,700 (37.1) 123,205 (36.0)
Data are n (%), unless otherwise indicated.
Table 2—RRs for hospitalizations associated with pneumonia
Exposure Case subjects Population control subjects Unadjusted RR (95%CI) Adjusted RR (95% CI)*
Diabetes
Absent 29,750 (86.9) 313,904 (91.7) 1.0 (reference) 1.0 (reference)
Present 4,489 (13.1) 28,486 (8.3) 1.68 (1.62–1.74) 1.26 (1.21–1.31)
Diabetes type
Diabetes absent 29,750 (86.9) 313,904 (91.7) 1.0 (reference) 1.0 (reference)
Type 1 diabetes 101 (0.3) 187 (0.1) 5.55 (4.34–7.08) 4.43 (3.40–5.77)
Type 2 diabetes 4,388 (12.8) 28,299 (8.3) 1.65 (1.59–1.71) 1.23 (1.19–1.28)
Duration of diabetes
Diabetes absent 29,750 (86.9) 313,904 (91.7) 1.0 (reference) 1.0 (reference)
5 years 1,941 (5.7) 12,903 (3.8) 1.60 (1.53–1.68) 1.21 (1.14–1.27)
5t o10 years 1,324 (3.9) 8,817 (2.6) 1.60 (1.51–1.70) 1.24 (1.16–1.32)
10 years 1,224 (3.6) 6,766 (2.0) 1.93 (1.81–2.06) 1.37 (1.28–1.47)
A1C
Diabetes absent 29,750 (86.9) 313,904 (91.7) 1.0 (reference) 1.0 (reference)
Diabetes present A1C 7% 1,149 (3.4) 7,500 (2.2) 1.64 (1.54–1.74) 1.22 (1.14–1.30)
Diabetes present A1C 7t o8% 607 (1.8) 3,999 (1.2) 1.62 (1.48–1.76) 1.23 (1.12–1.36)
Diabetes present A1C 8-9% 407 (1.2) 2,442 (0.7) 1.77 (1.59–1.97) 1.29 (1.15–1.44)
Diabetes present A1C 9% 568 (1.7) 2,664 (0.8) 2.26 (2.07–2.48) 1.60 (1.44–1.76)
Diabetes present A1C unknown 1,758 (5.1) 11,881 (3.5) 1.58 (1.50–1.66) 1.21 (1.14–1.28)
Data are n (%), unless otherwise indicated. *RRs adjusted for level of comorbidity, alcoholism-related conditions, use of systemic antibiotic therapy and immuno-
suppressants before index hospitalization, marital status, household presence of small children attending day care centers, and degree of urbanization.
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control and longer diabetes duration
clearly increased the risk of pneumonia-
related hospitalization. Also, the relative
impactofdiabeteswasgreatestinyounger
adults and in subjects without coexisting
morbidity.
Our data extend previous studies
(4,6,8–10) suggesting that diabetes is a
riskfactorforpneumonia.ADutchcohort
studycomparingdiabeticpatientswithan
age-matched control group of hyperten-
sive patients, based on records from 195
general practices, showed that diabetic
patients had a greater risk of lower respi-
ratory tract infections (adjusted OR for
patients with type 1 diabetes 1.42 [95%
CI 0.96–2.08] and for patients with type
2 diabetes 1.32 [1.13–1.53]) (6). How-
ever, the category “lower respiratory tract
infection” included milder general practi-
tioner–diagnosed cases of acute bronchi-
tis, inﬂuenza, pleuritis, emphysema or
chronic obstructive pulmonary disease,
and exacerbations of asthma in addition
to pneumonia. In a Canadian cohort
study, Shah et al. (9) compared all sub-
jects with diabetes in Ontario to matched
nondiabetic subjects (n  513,749 in
each group). In crude analyses, subjects
with diabetes had an increased risk of
pneumonia-related hospitalization or
physician claims for pneumonia treat-
ment (RR 1.46 [95% CI 1.42–1.49]). The
study did not clarify whether its result
wasinﬂuencedbyahigherlevelofcomor-
bidity among subjects with diabetes com-
pared with subjects without diabetes.
Jackson et al. (8) reported that the ad-
justedRRforhospitalizationsforcommu-
nity-acquired pneumonia was 1.52 (95%
CI 1.29–1.78) among subjects with dia-
betes compared with subjects without di-
abetes, based on 46,237 subjects aged
65 years enrolled in a single HMO in
Washingtonstate.Theseﬁndingsmaynot
be generalizable to subjects aged 65
years or to the general population.
The main strengths of our study in-
clude its large size, population-based de-
sign, and adjustment for important
confounders made possible through ac-
cess to medical databases providing a
complete medical and prescription his-
tory. Furthermore, despite inevitable
coding errors, the estimated predictive
valueofadischargediagnosisofpneumo-
nia in Denmark is 90% (2). The preva-
lence of type 2 diabetes cases identiﬁed in
this study is higher than in our previous
cohort study (12.8 vs. 9.8%) (19), due to
improved identiﬁcation of patients with
untreated type 2 diabetes. Finally, by us-
ing highly valid algorithms to collect data
on diabetes and possible confounding
factors before the date of hospitalization
for pneumonia, we were able to avoid the
recall bias present in case-control studies
based on interviews or questionnaires.
Limitations include the possibility
that physicians are more likely to admit a
diabetic patient with pneumonia to the
hospitalcomparedwithanondiabeticpa-
tient.Suchbiaswouldleadtooverestima-
tion of the RR associated with diabetes.
However, an earlier study (19) showed
that preadmission use of antibiotics, lev-
els of inﬂammatory markers, and propor-
tions of patients with at least one blood
culture were comparable among patients
with type 2 diabetes and nondiabetic pa-
tients hospitalized with pneumonia. This
suggests that there was not a severe bias
associated with treatment of patients with
type 2 diabetes. However, the possibility
remains that estimates for patients with
type1diabeteswereaffectedbyincreased
surveillance. A previous cohort study (8)
examining diabetes as a risk factor for
pneumonia-related hospitalizations and
Table3—RRsforhospitalizationassociatedwithpneumoniaaccordingtopresenceofdiabetes
(overall, type 1, and type 2), stratiﬁed by age, sex, and level of comorbidity
Unadjusted RR (95% CI) Adjusted RR (95% CI)*
Diabetes (overall)
Age (years)
15–39 3.93 (3.16–4.87) 3.21 (2.51–4.12)
40–64 2.63 (2.43–2.84) 1.65 (1.51–1.81)
65–79 1.64 (1.56–1.73) 1.22 (1.15–1.29)
80 1.33 (1.25–1.41) 1.11 (1.05–1.18)
Sex
Male 1.67 (1.60–1.75) 1.25 (1.19–1.32)
Female 1.69 (1.60–1.77) 1.26 (1.20–1.33)
Comorbidity index
Index low (0) 1.68 (1.58–1.79) 1.51 (1.41–1.61)
Index medium (1–2) 1.22 (1.15–1.30) 1.15 (1.08–1.22)
Index high (3) 1.15 (0.99–1.32) 1.11 (0.95–1.28)
Type 1 diabetes
Age (years)
15–39 6.41 (4.69–8.74) 5.15 (3.61–7.36)
40–64 4.67 (3.12–6.98) 3.43 (2.14–5.50)
65–79 — —
80 — —
Sex
Male 5.05 (3.68–6.94) 3.97 (2.81–5.60)
Female 6.38 (4.35–9.36) 5.28 (3.49–8.00)
Comorbidity index
Index low (0) 4.98 (3.67–6.74) 4.76 (3.43–6.61)
Index medium (1–2) 3.35 (0.88–12.78) 3.15 (0.80–12.38)
Index high (3) — —
Type 2 diabetes
Age (years)
15–39 2.63 (1.94–3.58) 2.15 (1.51–3.06)
40–64 2.58 (2.39–2.79) 1.62 (1.47–1.77)
65–79 1.64 (1.56–1.73) 1.22 (1.15–1.29)
80 1.33 (1.25–1.41) 1.11 (1.05–1.18)
Sex
Male 1.64 (1.57–1.72) 1.23 (1.17–1.29)
Female 1.66 (1.57–1.74) 1.24 (1.17–1.31)
Comorbidity index
Index low (0) 1.62 (1.52–1.73) 1.45 (1.36–1.55)
Index medium (1–2) 1.22 (1.15–1.29) 1.15 (1.07–1.22)
Index high (3) 1.15 (0.99–1.32) 1.11 (0.95–1.28)
*RRs adjusted for level of comorbidity (except when stratiﬁed by this variable), alcoholism-related condi-
tions, use of systemic antibiotic therapy and immunosuppressants before index hospitalization, marital
status, household presence of small children attending day care centers, and degree of urbanization.
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subjects who develop pneumonia are
more likely to be hospitalized than non-
diabetic subjects (hospitalizations for
pneumonia, adjusted RR 1.52; outpatient
visits for pneumonia, adjusted RR 0.90).
Wealsomayhaveunderestimatedthe
duration of diabetes due to undetected
type 2 diabetes. However, such misclassi-
ﬁcation is unlikely to be greater among
case subjects then among control sub-
jects. Moreover, lack of data precluded
adjustment for pneumococcal and inﬂu-
enza vaccinations, which may reduce the
risk of pneumonia. If patients with diabe-
tes were vaccinated at higher rates than
others,however,therelativeriskofpneu-
monia-related hospitalizations would be
underestimated and would not alter our
conclusions.
We found a difference in risk esti-
mates for pneumonia-related hospitaliza-
tion by type of diabetes, which agrees
with the study by Muller et al. (6). Pa-
tients with type 1 diabetes may be more
likely to seek medical attention and to be
hospitalized due to problems with glu-
cose regulation triggered by pneumonia
and risk of ketoacidosis. In addition to
increased surveillance, the higher risk of
pneumonia-related hospitalization in pa-
tientswithtype1diabetescomparedwith
thosewithtype2diabetescouldalsoarise
from different disease pathogenesis. Un-
like type 2 diabetes, type 1 diabetes is
characterizedbyreducedortotallyabsent
insulin secretion. Insulin may itself have
anti-inﬂammatory effects (20). Duration
of diabetes has an impact on the risk of
pneumonia-related hospitalizations, due
perhaps to worsening of microangio-
pathic changes in the basement mem-
branes of pulmonary blood vessels and
respiratory epithelium in diabetic sub-
jects (12).
We found that diabetes combined
with an A1C level 9% is associated with
a 60% increased risk of pneumonia-
related hospitalization, while diabetes
combined with an A1C level 7% was
associated with a 22% increased risk,
comparedwithsubjectswithoutdiabetes.
These results conﬁrm observations from
in vitro studies in which hyperglycemia
was associated with abnormalities in neu-
trophil function, such as impaired che-
motaxis, phagocytosis, and bacterial
killing (21). At the same time, our results
do not support the claim that “infections
are no commoner in well-controlled dia-
betics than in nondiabetics” (22) but
rather indicate that the increased suscep-
tibilitytopneumoniaamongdiabeticsub-
jects has a multifactorial etiology. We
found that the RR of pneumonia-related
hospitalization declined with age among
diabetic subjects. Young adults generally
have a low incidence of hospitalized
pneumonia, which may explain why the
relative impact of diabetes is higher.
In conclusion, our data, combined
with previous results, provide strong evi-
dence that diabetes is associated with a
25–75% increase in the RR of pneumo-
nia-related hospitalization. Longer dura-
tionofdiabetesandpoorglycemiccontrol
increase the risk of pneumonia-related
hospitalization. These results emphasize
the value of inﬂuenza and pneumococcal
immunization, particularly for patients
with longer diabetes duration, and the
importance of improved glycemic control
to prevent pneumonia-related hospital-
ization among diabetic patients.
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